Patents

US 12715922 B2: Anti-Galectin-9 antibodies and uses thereof

Granted
2026-08-25
Filed
2020-03-25 application 17598215
Type
Utility · 15 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Disclosed herein are anti-Galectin-9 antibodies and methods of using in modulating (e.g., increasing) immune responses in a subject, either taken alone or in combination with an immune checkpoint inhibitor, such as a PD-1 inhibitor.

Source: PTBLXML, file of 2026-08-25 (ipgb20260825.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
New York University 967 patentsUS company or organizationNew York, NYNew York University College or university EXACT high confidence: identical full name and state
NEW YORK UNIVERSITY Nonprofit EXACT high confidence: identical full name and state
PTBLXML, file of 2026-08-25
PureTech LYT, Inc. 8 patentsUS company or organizationBoston, MAPURETECH LYT, INC. State business registration EXACT high confidence: identical full name and statePTBLXML, file of 2026-08-25

Inventors

InventorPlacePatentsPerson pageSource
Shohei KoideNew York, NY96PTBLXML, file of 2026-08-25
George MillerNew York, NY11PTBLXML, file of 2026-08-25
Akiko KoideNew York, NY22PTBLXML, file of 2026-08-25
Linxiao ChenNew York, NY10PTBLXML, file of 2026-08-25
Aleksandra FilipovicLondon, GB7PTBLXML, file of 2026-08-25
Eric ElenkoBoston, MA17PTBLXML, file of 2026-08-25
Joseph BolenBoston, MA20PTBLXML, file of 2026-08-25

CPC categories

SubclassCategoryFirst groupSource
C07KPeptidesC07K16/2851PTBLXML, file of 2026-08-25
A61KPreparations for medical, dental or toiletry purposesA61K31/337PTBLXML, file of 2026-08-25
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P35/00PTBLXML, file of 2026-08-25

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2022-08-26Correction
Corrective assignment to correct the name of the first conveying party previously recorded on reel 060211 frame 0495. assignor(s) hereby confirms the assignment.
ELENKO, ERIC signed 2021-08-30
BOLEN, JOSEPH signed 2021-08-31
PURETECH MANAGEMENT, INC. BOSTON, MA61328/936PASDL, file of 2026-08-13
2022-06-15Assignment
Nunc pro tunc assignment
KOIDE, SHOHEI signed 2021-09-17
MILLER, GEORGE signed 2021-09-05
KOIDE, AKIKO signed 2021-09-17
CHEN, LINXIAO signed 2021-09-19
NEW YORK UNIVERSITY NEW YORK, NY60212/99PASDL, file of 2026-08-13
2022-06-15Assignment
Assignment of assignor's interest
PURETECH HEALTH LLC signed 2021-09-01PURETECH LYT, INC. BOSTON, MA60211/854PASDL, file of 2026-08-13
2022-06-15Assignment
Assignment of assignor's interest
FILIPOVIC, ALEKSANDRA signed 2021-09-01PURETECH HEALTH, LLC BOSTON, MA60211/748PASDL, file of 2026-08-13
2022-06-15Assignment
Assignment of assignor's interest
PURETECH MANAGEMENT, INC. signed 2021-09-01PURETECH HEALTH LLC BOSTON, MA60211/556PASDL, file of 2026-08-13
2022-06-15Assignment
Assignment of assignor's interest
ELENKO, ERIK signed 2021-08-30
BOLEN, JOSEPH signed 2021-08-31
PURETECH MANAGEMENT, INC. BOSTON, MA60211/495PASDL, file of 2026-08-13

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.